期刊文献+

阴道超声在药物流产中应用的价值探讨 被引量:1

Vaginal ultrasound in the value of application in medical abortion
原文传递
导出
摘要 目的探讨阴道超声监测孕囊大小及子宫位置与药物流产临床结局的相关性及临床应用价值。方法回顾性分析950例要求药物流产的孕妇,用药前阴道超声检查,服药后8天未排出孕囊为药流失败,服药孕囊自行排出后10天阴道超声复查仍有异常回声组织或阴道出血过多淋漓不净最终清宫者为药流失败。结果子宫位置中,后倾后屈位者药流失败率明显高于其他位置;孕囊<8mm组及>25mm组药物流产失败率高有显著差异(P<0.05)。结论阴道超声监测具有方便准确的优点,可监测药物流产效果,并指导临床处理。 Objective To investigate the relationship between gestational sacs(GS) size, Uterine position and medical abortion efficacy by transvaginal ultrasonography and its clinical application value. Methods Analyzing 950 pregnant women requirirlg medical abortion Vaginal ultrasound before using this drug For oral administration 8 days didn't see pregnant bursa belongs to medical abortion failure; Gestational sac discharge after 10 days, transvaginal ultrasonography showed abnormalities echo in the Uterine who s bleedi These ng cavity, and all subjects 11 had irregular vaginal were performed curettage, patients are classified as med The in and icine abortion failure. Results rate of medical abortion failure the case with retroverted retroflexton uterus were than that of others. The rates of medical abortion uterus higher ailing or the groups with GS size〈8 mm and GS size〉25 mm simwed sigilificant difference compared with other three groups(P〈0. 05). Conclusion Transvaginal ultrasonography was convenient to monitor the efficacy of medical abortion and guide clinical treatment.
出处 《首都食品与医药》 2015年第16期47-48,共2页 Capital Food Medicine
关键词 阴道超声检查 妊娠 药物流产 流产失败 Vaginal ultrasound Earlypregnancy medical abortion medicalabortion failure
  • 相关文献

参考文献4

二级参考文献19

  • 1ACOG Committee on Obstetric Practice.Committee opinion.Induction of labor for vaginal birth after cesarean delivery.Obstet Gynecol,2002,99(4):679-680
  • 2Hill DA,Chez RA,Quinlan J,et al.Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening.J Reprod Med,2000,45(10):823-826
  • 3Choy-Hee L,Raynor BD.Misoprostol induction of labor among women with a history of cesarean delivery.Am J Obstet Gynecol,2001,184(6):1115-1117
  • 4Ng PS,Chan AS,Sin WK,et al.A multicenter randomized controlled trial of oral misoprostol and i.m.syntometrine in the management of the third stage of labour.Hum Reprod,2001,16(1):31-35
  • 5Danielsson KG,Marions L,Rodriguez A,et al.Comparison between oral and vaginal administration of misoprostol on uterine contractility.Obstet Gynecol,1999,93(2):275-280
  • 6Honkanen H,Ranta S,Ylikorkala O,et al.The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy.Hum Reprod,2002,17(9):2315-2319
  • 7Orioli IM,Castilla EE.Epidemiological assessment of misoprostol teratogenicity.BJOG,2000,107(4):519-523
  • 8Baird DT.Medical abortion in the first trimester.Best Pract Res Clin Obstet Gynaecol,2002,16(2):221-236
  • 9Jain JK,Dutton C,Harwood B,et al.A prospective randomized,double-blinded,placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.Hum Reprod,2002,17(6):1477-1482
  • 10Wiebe E,Dunn S,Guilbert E,et al.Comparison of abortions induced by methotrexate or mifepristoine followed by misoprostol.Obstet Gynecol,2002,99(5pt1):813-819

共引文献567

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部